Skip to content

Speech Therapy and Covid-19

Effects of Speech Therapy Intervention on Communicative, Cognitive, Olfactory and Swallowing Sequelae in patients with Severe presentation of Covid-19

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-23k6dgq
Enrollment
Unknown
Registered
2023-12-30
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Communication Disorders

Interventions

Prospective, controlled, randomized, parallel, triple-blinded study, based on the list of patients with severe Covid-19 from two Public Hospitals in Sergipe (one in the inner city and the other in the

Sponsors

Universidade Federal de Sergipe
Lead Sponsor
Universidade Federal de Sergipe
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Subjects of any gender; residing and born in Brazil; aged over 18 years; people who had severe Covid-19; and patients who remained hospitalized

Exclusion criteria

Exclusion criteria: People who at some point in the research withdrew their free and informed consent; who have difficulty in orally answering the questionnaires; with cognitive and speech-language impairments prior to hospitalization; bedridden due to the difficulty of locomotion to participate in the research; those who test positive for Covid -19 at the time of the evaluations (due to the need to comply with isolation and the possibility of interfering in the acute phase of the disease with the test results); with reinfection of Covid-19 during the intervention period; with presence of hearing loss for admission to the language and cognition therapy group; patients with drug use that interfere with rehabilitation in the smell and swallowing therapy group

Design outcomes

Primary

MeasureTime frame
It is expected to obtain Normosmia (by evaluating the Olfactory Threshold and Identifying Odors from the Connecticut Test): values between Six and Seven points;Swallowing is expected to be Normal or Functional (according to the Asha Noms and FOIS Scales: Level Seven);It is expected that Cognitive Function (verified by the Brief Neuropsychological Assessment - Neupsilin) is within the expected range for the patient's Age and Education (z Score between 0.99 and -0.99);It is expected that the Language (assessed by the Semantic Verbal Fluency Test) is compatible with the patient's Age and Education (z score between 0.99 and -0.99)

Secondary

MeasureTime frame
No secondary outcomes are expected

Countries

Brazil

Contacts

Public ContactKelly Silva

Universidade Federal de Sergipe

kelly.silva@academico.ufs.br+55(79)3632-2103

Outcome results

None listed

Source: REBEC (via WHO ICTRP)